Fennec Pharmaceuticals
FENC
55 hedge funds and large institutions have $116M invested in Fennec Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 18 increasing their positions, 4 reducing their positions, and 5 closing their positions.
540% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 5
350% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 4
106% more capital invested
Capital invested by funds: $56.3M → $116M (+$59.6M)
90% more funds holding
Funds holding: 29 → 55 (+26)
7.1% more ownership
Funds ownership: 47.6% → 54.7% (+7.1%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more call options, than puts
Call options by funds: $273K | Put options by funds: $273K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$7.7M |
| 2 |
SFI
Sonic Fund II
Honolulu,
Hawaii
|
+$5.95M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
+$4.19M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$2.97M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$185K |
| 2 |
Millennium Management
New York
|
-$114K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$110K |
| 4 |
WQ
Wealth Quarterback
Toms River,
New Jersey
|
-$5.94K |
| 5 |
MAM
Meeder Asset Management
Dublin,
Ohio
|
-$3.94K |
FENC Hedge Fund Activity: Q2 2020 in Review
55 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Fennec Pharmaceuticals (FENC) for Q2 2020, worth a combined $116M — up 106% from $56.3M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new FENC positions and 5 closed out — a net gain of 27 holders — while 18 added to existing stakes and 4 trimmed.
The largest buyer was BlackRock, adding an estimated $7.7M. The largest seller was Granahan Investment Management, cutting an estimated $185K.
- 55 institutional investors held Fennec Pharmaceuticals (FENC) as of Q2 2020, up from 29 in Q1 2020.
- Funds reported $116M of Fennec Pharmaceuticals stock for Q2 2020, up 106% quarter-over-quarter.
- 32 funds opened new Fennec Pharmaceuticals positions in Q2 2020 and 5 closed out, a net change of +27 holders.
- The largest Fennec Pharmaceuticals buyer in Q2 2020 was BlackRock, an estimated $7.7M added.
- The largest Fennec Pharmaceuticals seller in Q2 2020 was Granahan Investment Management, an estimated $185K sold.
Based on aggregated 13F filings for Q2 2020.